A nasal spray formulation of bumetanide has been shown to be safe and effective in a new study and could ultimately prevent ...

The active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...

FDA reported that, for now, companies can continue to market OTC monograph drug products containing oral phenylephrine as a ...

Italian researchers have developed a nasal spray showing promise in slowing Alzheimer's progression. Tests on mice with ...

Limitless Biotech, a leading innovator in the field of biohacking and cognitive enhancement, is proud to announce the launch ...

A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione ...

Bumetanide nasal spray (BNS) has statistical bioequivalence to oral bumetanide, according to a research letter publish ...

New research highlights nasal spray drug’s potential to counter Alzheimer’s by targeting brain enzyme dysfunction.

A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...

Researchers at Tel Aviv University have developed an effective, inexpensive, and simple COVID-19 vaccine that can be stored ...

The Federal Government is funding a national Take Home Naloxone (THN) program that makes the life-saving medication available ...

Alzheimer's wonder drugs aren't yet delivering on their promise. American researchers have come up with a brand new idea, a ...